I way I look at this company is that its currently valued significantlybelow its replacement cost (very low Q-ratio) and therefore future downside islimited from this point (bear case). My base case is for a steady continuationof improvements in current businesses with share prices returning to cap raiselevels and bull case sees a huge spike once bio-dynamic organic infant formulais announced. Launching into a new niche segment of the IF market with LBsteering the ship will see the hype of 2017 return.
Intrinsic Value, page-15
Add MBH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
7.2¢ |
Change
0.001(1.41%) |
Mkt cap ! $25.37M | |||
| Open | High | Low | Value | Volume |
| 7.2¢ | 7.2¢ | 7.1¢ | $35.47K | 492.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 468183 | 7.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 7.4¢ | 44391 | 2 |
View Market Depth
| Last trade - 13.44pm 15/05/2024 (20 minute delay) ? |
|
|||||
|
Last
7.2¢ |
Change
0.001 ( 1.41 %) |
||||
| Open | High | Low | Volume | ||
| 7.2¢ | 7.2¢ | 7.1¢ | 30385 | ||
| Last updated 13.44pm 15/05/2024 ? | |||||
| MBH (ASX) Chart |